NovaBone Products was established in 2002 with a focus on developing biomaterials that harness the body’s natural healing process while meeting the specialized needs of orthopedic and dental surgeons.
Headquartered in Jacksonville, Florida, NovaBone has operations and R&D facility in Alachua, FL. In March 2014, NovaBone relocated into a 30,000 sq. ft. building, more than doubling the previous footprint and combining the company’s manufacturing and R&D operations under one roof.
NovaBone has developed numerous formulations and delivery systems of its bioactive technology platform that results in accelerated bone growth. The exclusively formulated bone graft substitute has been used for the repair of osseous defects throughout the skeletal system.
NovaBone Products offered the first bioactive glass product to the medical community and demonstrated that its technology platform recruits, differentiates and proliferates bone cells. Today, the company offers a wide portfolio of biologic products that include bone formation products, as well as collagen products that repair and remodel soft tissue.
NovaBone’s graft substitutes and collagen devices have been used for nearly two decades in millions of clinical applications with unparalleled success validating the safety and efficacy of our technology.
NovaBone Quality Policy details our commitment to our responsibilities.
Develop products with useful clinical efficacy that improve patients' health and quality of life while offering medical caregivers ease of use and convenience.
Manufacture products that consistently meet performance criteria and customer expectations.
Strive to continuously improve the quality of our products, the skills of our team members, the effectiveness of our processes, and the profitability of our business.
To operate in conformance with domestic and international medical device regulations.
Conduct our business with the highest level of integrity.
NovaBone's resorbable bioactive synthetic and collagen formulations optimize osteogenesis, signal and stimulate osteoblastic activity, and offer angiogenic potential. The technology has proven to out-perform traditional calcium sulfate-based synthetic products and demineralized bone matrix products
NovaBone Products manufactures novel synthetic bone grafting materials proven to signal the body’s genetic pathways to build healthy bone fast (1). NovaBone bone graft substitutes control the osteoblast cycle to favor proliferation and differentiation of bone-forming cells(2)
Unlike other synthetic grafts that are bioinert, NovaBone bone grafts belong to the class of bioactive regenerative materials that not only acts as an osteoconductive scaffold but also interacts with the surrounding tissues and imparts an Osteostimulatory effect(3)
NovaBone offers the industry first and only bone graft substitute dispensed in a single dose, ready to use cartridges. NovaBone Dental Putty is the only graft material in the world that simplify the delivery of graft into the defect
NovaBone’s unique resorbable bioactive bone graft substitutes and collagen wound dressings are engineered for enhancing handling and improved performance on each specific clinical indication to meet the demanding dental surgeon's needs
NovaBone's bone graft substitutes and collagen matrix devices have been used for nearly two decades in millions of clinical applications with unparalleled success validating the safety and efficacy of our technology. Made in the U.S.A.
NovaBone is a Halma company. Halma is a global group of life-saving technology companies with a clear purpose to grow a safer, cleaner, healthier future for everyone, every day.